Evidence map›Paper›PMID 31758704›Full record

ArticleBritish journal of pharmacology2020

Inactivation of Cys

Gang Liu, Fuhua Wu, Xiaoli Jiang, Yumei Que, Zhexue Qin, Pingping Hu, Kin Sing Stephen Lee, Jian Yang, Chunyu Zeng, Bruce D Hammock and 1 more

Open access · greenAbstract read
In one paragraph

Article in British journal of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Reactive oxygen species in hypertension.Nature reviews. Cardiology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Oxidative Stress and Hypertension.Circulation research · 2021
    Review
  10. Inactivation of CysBritish journal of pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Gang LiuSchool of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Fuhua WuSchool of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Xiaoli JiangSchool of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Yumei QueSchool of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Zhexue QinDepartment of Cardiovascular Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Pingping HuSchool of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Kin Sing Stephen LeeDepartment of Entomology & UCD Comprehensive Cancer Center, University of California-Davis, Davis, California.
Jian YangDepartment of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chunyu ZengDepartment of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China.
Bruce D HammockDepartment of Entomology & UCD Comprehensive Cancer Center, University of California-Davis, Davis, California.ORCID 0000-0003-1408-8317
Xiaoyong TongSchool of Pharmaceutical Sciences, Chongqing University, Chongqing, China.ORCID 0000-0002-0553-6723
Chongqing University · CNArmy Medical University · CNUC Davis Comprehensive Cancer CenterChongqing Medical University · CN

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
HYDROLYTIC ENZYMES IN THE METABOLISM OF TOXINSR01ES002710 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1985 to 2018
$4.0M
HYDROLYTIC ENZYMES IN THE METABOLISM OF TOXINSR37ES002710 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1998 to 2007
$3.0M
Eicosanoid-based Therapy for DiabetesR01DK103616 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI IMIG, JOHN D · 2015 to 2019
$2.4M
Identifying the receptors of environmentally sensitive epoxy-eicosanoids with AMSR00ES024806 · NIEHS · MICHIGAN STATE UNIVERSITY · PI LEE, KIN SING STEPHEN · 2017 to 2019
$727k
Chongqing Research Program of Basic Research and Frontier Technology cstc2016jcyjA0407Fundamental Research Funds for the Central Universities 2018CDQYYX0042National Natural Science Foundation of China 31571172National Natural Science Foundation of China 81700237National Natural Science Foundation of China 81870343NIDDK NIH HHS R01 DK103616NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R00 ES024806NIEHS NIH HHS R01 ES002710NIEHS NIH HHS R37 ES002710
6 · The paper itself

Abstract

background and purposeThe kidney is essential in regulating sodium homeostasis and BP. The irreversible oxidation of Cys EXPERIMENTAL APPROACH: We used heterozygous SERCA2 C674S knock-in (SKI) mice, where half of C674 was substituted by serine, to represent partial irreversible oxidation of C674. The BP, urine volume, and urine composition of SKI mice and their littermate wild-type (WT) mice were measured. The kidneys were collected for cell culture, Na KEY

resultsCompared with WT mice, SKI mice had higher BP, lower urine volume and sodium excretion, up-regulated endoplasmic reticulum (ER) stress markers and soluble epoxide hydrolase (sEH), and down-regulated dopamine D CONCLUSIONS AND IMPLICATIONS: The inactivation of SERCA2 C674 promotes the development of hypertension by inducing ER stress and sEH. Our study highlights the importance of C674 redox status in BP control and the contribution of SERCA2 to sodium homeostasis and BP in the kidney.

Indexed as

Blood PressureEndoplasmic Reticulum StressEpoxide HydrolasesHypertensionSarcoplasmic Reticulum Calcium-Transporting ATPasesAnimalsKidneyMiceOxidation-ReductionAtp2a2 protein, mouseEpoxide HydrolasesSarcoplasmic Reticulum Calcium-Transporting ATPases

Identifiers

PMID31758704
PMCPMC7070168
OpenAlexW2989927145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.